V009-0913 Screening compound: N-(3-methylbutyl)-N-{2-oxo-2-[4-(phenoxymethyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]ethyl}thiophene-2-carboxamide

V009-0913 Screening compound: N-(3-methylbutyl)-N-{2-oxo-2-[4-(phenoxymethyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]ethyl}thiophene-2-carboxamide
V009-0913 Screening compound: N-(3-methylbutyl)-N-{2-oxo-2-[4-(phenoxymethyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]ethyl}thiophene-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-0913
N-(3-methylbutyl)-N-{2-oxo-2-[4-(phenoxymethyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]ethyl}thiophene-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-0913

Molecular Formula

C26H30N2O3S2 (C26 H30 N2 O3 S2)

Compound Name

N-(3-methylbutyl)-N-{2-oxo-2-[4-(phenoxymethyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]ethyl}thiophene-2-carboxamide

IUPAC name

N-(3-methylbutyl)-N-{2-oxo-2-[4-(phenoxymethyl)-4H5H6H7H-thieno[32-c]pyridin-5-yl]ethyl}thiophene-2-carboxamide

SMILES

CC(C)CCN(CC(N(CC1)C(COc2ccccc2)c2c1scc2)=O)C(c1cccs1)=O

InChI

InChI=1S/C26H30N2O3S2/c1-19(2)10-13-27(26(30)24-9-6-15-32-24)17-25(29)28-14-11-23-21(12-16-33-23)22(28)18-31-20-7-4-3-5-8-20/h3-9,12,15-16,19,22H,10-11,13-14,17-18H2,1-2H3/t22-/m0/s1

InChI Key

CBVLIEGEZRMWAX-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD19866257

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.67

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.697

Distribution Coefficient, logD

5.697

Water Solubility, LogSw

-5.46

Polar Surface Area

41.283

Acid Dissociation Constant (pKa)

23.58

Base Dissociation Constant (pKb)

2.82

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.50

V009-0913 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with V009-0913 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-0913?
Check Price and Availability of V009-0913, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-0913 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-0913
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-0913
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-0913 available by request